Max Healthcare to Build 450-Bed Super Speciality Hospital in Pune; Stock Gains Nearly 3%
Max Healthcare to Build 450-Bed Super Speciality Hospital in Pune; Stock Gains Nearly 3%
Investor sentiment around Max Healthcare Institute turned positive on December 18 after the company revealed a major expansion plan in western India. The announcement of a new super speciality hospital in Pune helped the stock rebound sharply, ending a brief losing streak in the market. Following the disclosure, shares of Max Healthcare climbed as much as 3 percent during intraday trade, touching a high of ₹1,060.90. Although some gains were trimmed later in the session, the stock still closed nearly 2 percent higher at ₹1,048 per share.
According to a regulatory filing, the board of Max Healthcare has cleared a proposal to acquire a 100 percent equity stake in Yerawada Properties Private Limited (YPPL), a Pune-based real estate company. The acquisition will enable Max to develop a large greenfield hospital project in the city.
The transaction, valued at around ₹200 crore, will be executed in a phased or “step-up” structure. In the initial tranche, Max Healthcare will acquire all Class A equity shares of YPPL, which provide full voting rights and account for approximately 50.22 percent of the economic interest in the company. The remaining Class B equity shares will be acquired gradually over the next four years.
Completion of the acquisition is linked to regulatory milestones, including the receipt of the Occupancy Certificate for the proposed hospital building. The entire process is expected to conclude within four years.
Alongside the acquisition, Max Healthcare’s board has also approved an investment of up to ₹1,020 crore to develop a 450-bed super speciality hospital in Pune. This total outlay covers multiple components, including the cost of acquiring Yerawada Properties, construction expenses, medical equipment, stamp duty, registration charges, and other related costs. The hospital will come up on a 1.68-acre freehold land parcel in Yerwada , a central and well-connected area of Pune. Yerawada Properties is currently engaged in real estate development and owns the land earmarked for the project.
Max Healthcare stated that the new facility will significantly strengthen its presence in Maharashtra and address the rising demand for advanced healthcare services in Pune and nearby regions, driven by population growth and an expanding middle class.
Commenting on the development, Chairman and Managing Director Abhay Soi highlighted Pune’s importance as a fast-growing urban hub with a strong economic foundation. He noted that the city’s evolving healthcare needs call for high-quality, technology-driven medical facilities—an area where Max Healthcare has established expertise.
He also described the Pune hospital as a strategic milestone for the company, marking its formal entry into the city. According to Soi, this project is likely to be the first of several initiatives Max Healthcare plans to undertake in the Pune market as part of its broader long-term expansion strategy.
The upcoming Pune hospital will be Max Healthcare’s fourth facility in Maharashtra. The company already operates the 350-bed Nanavati Max Hospital in Mumbai and the 212-bed Alexis Hospital in Nagpur. Additionally, it has signed an agreement to develop a 500-bed greenfield hospital in Thane.
The Pune project will be Max’s second greenfield investment in western India. The hospital is expected to be commissioned within the next three years, while the full 450-bed capacity will be added in phases over four years. Funding for the project will be arranged through a mix of internal accruals and term loans.
People familiar with the company’s plans indicated that Max Healthcare is currently focused on deepening its footprint within Maharashtra, rather than expanding into other western states. At present, Max Healthcare operates around 5,200 beds nationwide, with approximately 750 beds located in Mumbai and Nagpur, including a newly added tower at Nanavati Max Hospital.
Despite the positive market reaction to the Pune announcement, Max Healthcare’s stock has faced some pressure in recent weeks. Shares are down more than 3 percent over the past five days, over 6 percent in the last month, and more than 11 percent over the past six months. The company currently trades at a price-to-earnings ratio of 87.40.
